During dental treatment involving invasive procedures such as tooth extraction, osteoporosis drugs such as bisphosphonates, receptor activators of nuclear factor-kappa B ligand (RANKL) antibodies, and antithrombotic drugs may adversely affect treatment [12-14]. The gene discussed is TNFSF11; the disease is osteoporosis.